Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ANTENGENE-CORPORATION-LIM-119080108/news/Antennova-Completes-First-Dosing-Cohort-for-Anti-CD24-mAb-ATN-031-in-the-Phase-I-PERFORM-Study-46242669/?utm_source=whatsapp&utm_medium=social&utm_campaign=share